• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

技术成功率、中期原发性通畅率以及影响内膜下血管成形术联合血管模拟支架置入术治疗跨大西洋协作组(TASC)II C型和D型股腘动脉疾病原发性通畅率的因素——一项前瞻性研究

Technical Success, Midterm Primary Patency, and Factors Affecting Primary Patency of Subintimal Angioplasty Followed by Vasculomimetic Stenting for Trans-Atlantic Intersociety Consensus II C and D Femoropopliteal Arterial Disease-A Prospective Study.

作者信息

Joseph Ansan, Valakkada Jineesh, Ayappan Anoop, Kannath Santhosh, Shivanesan Pitchai

机构信息

Department of Imaging Sciences and Interventional Radiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.

Department of Vascular Surgery, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.

出版信息

Indian J Radiol Imaging. 2023 Dec 4;34(2):254-261. doi: 10.1055/s-0043-1777015. eCollection 2024 Apr.

DOI:10.1055/s-0043-1777015
PMID:38549898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10972645/
Abstract

The best option among the endovascular options in long, complex femoropopliteal (FP) lesions, and factors affecting the patency have yet to be well described. There are few studies describing the mid- and long-term patency of endovascular stents in long-segment FP occlusions.  This study aimed to determine the technical success and mid-term patency of subintimal angioplasty with vasculomimetic stenting in Trans-Atlantic Inter-Society Consensus II (TASC) C and D FP disease. The patient and imaging factors that affect primary patency were also analyzed.  A single-center prospective study was performed on 52 consecutive patients undergoing endovascular treatment for TASC C and D FP disease from 2017 to 2021. Angioplasty with stenting was performed in all patients and followed up for 36 months. Endpoints were primary patency rates and amputation-free survival of the limb. Kaplan-Meier curves were used to see patency rates and amputation-free survival rates.  A total of 52 patients underwent stenting with a technical success rate of 100% if the sub-intimal arterial flossing with antegrade-retrograde intervention (SAFARI) technique was used. Primary stent patency at 6, 12, 18, 24, and 36 months was 89.8, 81.4, 76.2, 71.4, and 62.5%, respectively. Amputation-free survival was 98, 95.6, 91.8, and 85.7% at 12, 24, 30, and 36 months, respectively. Cox proportional regression analysis showed smoking and vessel wall calcium score more than 270 degrees as independent predictors of loss of primary patency (hazard ratio 0.35 confidence interval [CI]: 0.003-0.448) and 0.102 (CI: 0.022-0.47), respectively.  Subintimal angioplasty with vasculomimetic stent has good midterm patency in and amputation-free survival in long-segment FP occlusions. Smoking and severe vessel wall calcification adversely affect patency.

摘要

在长段、复杂的股腘(FP)病变的血管内治疗方案中,最佳选择以及影响通畅率的因素尚未得到充分描述。很少有研究描述血管内支架在长段FP闭塞中的中长期通畅情况。本研究旨在确定在跨大西洋两岸血管外科学会共识II(TASC)C和D级FP疾病中,采用血管模拟支架的内膜下血管成形术的技术成功率和中期通畅率。还分析了影响原发性通畅的患者和影像学因素。对2017年至2021年连续52例接受TASC C和D级FP疾病血管内治疗的患者进行了单中心前瞻性研究。所有患者均接受了支架血管成形术,并随访36个月。终点指标为原发性通畅率和肢体无截肢生存率。采用Kaplan-Meier曲线观察通畅率和无截肢生存率。如果采用顺行-逆行介入内膜下动脉梳理(SAFARI)技术,共有52例患者接受了支架置入术,技术成功率为100%。支架在6、12、18、24和36个月时的原发性通畅率分别为89.8%、81.4%、76.2%、71.4%和62.5%。在12、24、30和36个月时,无截肢生存率分别为98%、95.6%、91.8%和85.7%。Cox比例回归分析显示,吸烟和血管壁钙化评分超过270°分别是原发性通畅丧失的独立预测因素(风险比0.35,置信区间[CI]:0.003-0.448)和0.102(CI:0.022-0.47)。采用血管模拟支架的内膜下血管成形术在长段FP闭塞中具有良好的中期通畅率和无截肢生存率。吸烟和严重的血管壁钙化会对通畅率产生不利影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d3c/10972645/1551215794b5/10-1055-s-0043-1777015-i2382904-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d3c/10972645/43e3be557fd6/10-1055-s-0043-1777015-i2382904-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d3c/10972645/be2731b65fe9/10-1055-s-0043-1777015-i2382904-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d3c/10972645/1551215794b5/10-1055-s-0043-1777015-i2382904-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d3c/10972645/43e3be557fd6/10-1055-s-0043-1777015-i2382904-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d3c/10972645/be2731b65fe9/10-1055-s-0043-1777015-i2382904-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d3c/10972645/1551215794b5/10-1055-s-0043-1777015-i2382904-3.jpg

相似文献

1
Technical Success, Midterm Primary Patency, and Factors Affecting Primary Patency of Subintimal Angioplasty Followed by Vasculomimetic Stenting for Trans-Atlantic Intersociety Consensus II C and D Femoropopliteal Arterial Disease-A Prospective Study.技术成功率、中期原发性通畅率以及影响内膜下血管成形术联合血管模拟支架置入术治疗跨大西洋协作组(TASC)II C型和D型股腘动脉疾病原发性通畅率的因素——一项前瞻性研究
Indian J Radiol Imaging. 2023 Dec 4;34(2):254-261. doi: 10.1055/s-0043-1777015. eCollection 2024 Apr.
2
Subintimal angioplasty for lower limb arterial chronic total occlusions.内膜下血管成形术治疗下肢动脉慢性完全闭塞病变
Cochrane Database Syst Rev. 2016 Nov 18;11(11):CD009418. doi: 10.1002/14651858.CD009418.pub3.
3
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.下肢外周动脉疾病的支架置入术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.
4
Long-term outcomes and predictors of iliac angioplasty with selective stenting.髂血管成形术联合选择性支架置入术的长期疗效及预测因素
J Vasc Surg. 2005 Sep;42(3):466-75. doi: 10.1016/j.jvs.2005.05.002.
5
Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.腔内治疗 TASC II D 型股腘动脉病变在伴有严重肢体缺血的患者。
J Vasc Surg. 2019 May;69(5):1510-1518. doi: 10.1016/j.jvs.2018.08.176. Epub 2019 Jan 2.
6
Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions.股腘动脉 TASC II C 和 D 型病变的镍钛诺支架血管内治疗的长期结果。
Medicina (Kaunas). 2022 Sep 5;58(9):1225. doi: 10.3390/medicina58091225.
7
Infrainguinal atherectomy: a retrospective review of a single-center experience.腹股沟下动脉粥样斑块切除术:单中心经验的回顾性分析
Ann Vasc Surg. 2008 Nov;22(6):776-82. doi: 10.1016/j.avsg.2008.08.003.
8
Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.股腘动脉自膨式镍钛合金支架置入术后中期临床结果及血管通畅性的预测因素。
J Vasc Surg. 2010 Sep;52(3):608-15. doi: 10.1016/j.jvs.2010.03.050. Epub 2010 Jun 22.
9
Subintimal angioplasty of chronic total occlusion in iliac arteries: a safe and durable option.髂动脉慢性全闭塞的内膜下血管成形术:一种安全且持久的选择。
J Vasc Surg. 2011 Feb;53(2):367-73. doi: 10.1016/j.jvs.2010.08.073. Epub 2010 Oct 27.
10
Mid-Term Outcomes of Endovascular Treatment for TASC-II D Femoropopliteal Occlusive Disease with Critical Limb Ischemia.腔内治疗 TASC-II D 型股腘动脉闭塞性病变合并严重肢体缺血的中期结果。
Cardiovasc Intervent Radiol. 2016 Mar;39(3):344-52. doi: 10.1007/s00270-015-1175-3. Epub 2015 Jul 23.

本文引用的文献

1
Nitinol Stent Versus Bypass in Long Femoropopliteal Lesions: 2-Year Results of a Randomized Controlled Trial.镍钛诺支架与旁路治疗长段股浅动脉病变:一项随机对照试验的 2 年结果。
JACC Cardiovasc Interv. 2019 Dec 23;12(24):2541-2549. doi: 10.1016/j.jcin.2019.09.006. Epub 2019 Nov 27.
2
Global vascular guidelines on the management of chronic limb-threatening ischemia.全球血管指南:慢性肢体威胁性缺血的管理。
J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28.
3
The BEST-CLI trial is nearing the finish line and promises to be worth the wait.
BEST-CLI 试验即将接近尾声,值得我们期待。
J Vasc Surg. 2019 Feb;69(2):470-481.e2. doi: 10.1016/j.jvs.2018.05.255.
4
Long-Term Primary Patency Rate After Nitinol Self-Expandable Stents Implantation in Long, Totally Occluded Femoropopliteal (TASC II C & D) Lesions.镍钛诺自膨式支架植入治疗长段、完全闭塞的股腘动脉(TASC II C型和D型)病变后的长期原发性通畅率
Heart Lung Circ. 2017 Jun;26(6):604-611. doi: 10.1016/j.hlc.2016.09.011. Epub 2016 Nov 18.
5
Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease.血管外科学会关于慢性下肢外周动脉疾病血管内治疗的报告标准。
J Vasc Surg. 2016 Jul;64(1):e1-e21. doi: 10.1016/j.jvs.2016.03.420.
6
Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients.TASC C和D级股腘动脉病变的初次支架置入术:一项针对203例患者的多中心试验的一年结果
J Cardiovasc Surg (Torino). 2018 Jun;59(3):392-404. doi: 10.23736/S0021-9509.16.09282-X. Epub 2016 Jun 7.
7
Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease.钙负荷评估及其对外周动脉疾病中药物洗脱球囊的影响。
Cardiovasc Intervent Radiol. 2014 Aug;37(4):898-907. doi: 10.1007/s00270-014-0904-3. Epub 2014 May 9.
8
Nitinol self-expanding stents vs. balloon angioplasty for very long femoropopliteal lesions.用于治疗非常长的股腘动脉病变的镍钛诺自膨胀支架与球囊血管成形术的比较
J Endovasc Ther. 2014 Feb;21(1):34-43. doi: 10.1583/13-4399MR.1.
9
One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA "STEnting Long de L'Artère fémorale superficielle" cohort).股浅动脉支架置入术治疗跨大西洋介入学会共识(TASC)C 和 D 型股腘病变的 1 年临床结果(STELLA“STEnting Long de L'Artère fémorale superficielle”队列)。
Eur J Vasc Endovasc Surg. 2012 Oct;44(4):432-41. doi: 10.1016/j.ejvs.2012.07.015. Epub 2012 Aug 21.
10
The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries.镍钛诺支架置入股腘动脉后,胫骨血管的数量并不影响初始通畅率。
J Vasc Surg. 2012 Apr;55(4):994-1000; discussion 1000. doi: 10.1016/j.jvs.2011.10.106. Epub 2012 Jan 14.